Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world : an observational cohort study
Copyright © 2019 Elsevier Ltd. All rights reserved..
BACKGROUND: To our knowledge, the characteristics and burden of childhood arthritis have never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study, the prevalence of disease categories, treatment methods, and disease status in patients from across different geographical areas and from countries with diverse wealth status.
METHODS: In this multinational, cross-sectional, observational cohort study, we asked international paediatric rheumatologists from specialised centres to enrol children with a diagnosis of juvenile idiopathic arthritis, according to International League of Associations for Rheumatology criteria, who were seen consecutively for a period of 6 months. Each patient underwent retrospective and cross-sectional assessments, including measures of disease activity and damage and questionnaires on the wellbeing and quality of life of the children. We qualitatively compared the collected data across eight geographical areas, and we explored an association between disease activity and damage and a country's gross domestic product (GDP) with a multiple logistic regression analysis.
FINDINGS: Between April 4, 2011, and Nov 21, 2016, 9081 patients were enrolled at 130 centres in 49 countries, grouped into eight geographical areas. Systemic arthritis (125 [33·0%] of 379 patients) and enthesitis-related arthritis (113 [29·8%] of 379) were more common in southeast Asia, whereas oligoarthritis was more prevalent in southern Europe (1360 [56·7%] of 2400) and rheumatoid factor-negative polyarthritis was more frequent in North America (165 [31·5%] of 523) than in the other areas. Prevalence of uveitis was highest in northern Europe (161 [19·1%] of 845 patients) and southern Europe (450 [18·8%] of 2400) and lowest in Latin America (54 [6·4%] of 849), Africa and Middle East (71 [5·9%] of 1209), and southeast Asia (19 [5·0%] of 379). Median age at disease onset was lower in southern Europe (3·5 years, IQR 1·9-7·3) than in other regions. Biological, disease-modifying antirheumatic drugs were prescribed more frequently in northern Europe and North America than in other geographical settings. Patients living in countries with lower GDP had greater disease activity and damage than those living in wealthier countries. Damage was associated with referral delay.
INTERPRETATION: Our study documents a variability in prevalence of disease phenotypes and disparities in therapeutic choices and outcomes across geographical areas and wealth status of countries. The greater disease burden in lower-resource settings highlights the need for public health efforts aimed at improving equity in access to effective treatments and care for juvenile idiopathic arthritis.
FUNDING: IRCCS Istituto Giannina Gaslini.
| Errataetall: |
CommentIn: Lancet Child Adolesc Health. 2019 Apr;3(4):204-206. - PMID 30819661 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
The Lancet. Child & adolescent health - 3(2019), 4 vom: 07. Apr., Seite 255-263 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Consolaro, Alessandro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antirheumatic Agents |
|---|
| Anmerkungen: |
Date Completed 14.05.2020 Date Revised 14.05.2020 published: Print-Electronic CommentIn: Lancet Child Adolesc Health. 2019 Apr;3(4):204-206. - PMID 30819661 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S2352-4642(19)30027-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM294440461 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM294440461 | ||
| 003 | DE-627 | ||
| 005 | 20231225081500.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2352-4642(19)30027-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0981.xml |
| 035 | |a (DE-627)NLM294440461 | ||
| 035 | |a (NLM)30819662 | ||
| 035 | |a (PII)S2352-4642(19)30027-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Consolaro, Alessandro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world |b an observational cohort study |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2020 | ||
| 500 | |a Date Revised 14.05.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Lancet Child Adolesc Health. 2019 Apr;3(4):204-206. - PMID 30819661 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Ltd. All rights reserved. | ||
| 520 | |a BACKGROUND: To our knowledge, the characteristics and burden of childhood arthritis have never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study, the prevalence of disease categories, treatment methods, and disease status in patients from across different geographical areas and from countries with diverse wealth status | ||
| 520 | |a METHODS: In this multinational, cross-sectional, observational cohort study, we asked international paediatric rheumatologists from specialised centres to enrol children with a diagnosis of juvenile idiopathic arthritis, according to International League of Associations for Rheumatology criteria, who were seen consecutively for a period of 6 months. Each patient underwent retrospective and cross-sectional assessments, including measures of disease activity and damage and questionnaires on the wellbeing and quality of life of the children. We qualitatively compared the collected data across eight geographical areas, and we explored an association between disease activity and damage and a country's gross domestic product (GDP) with a multiple logistic regression analysis | ||
| 520 | |a FINDINGS: Between April 4, 2011, and Nov 21, 2016, 9081 patients were enrolled at 130 centres in 49 countries, grouped into eight geographical areas. Systemic arthritis (125 [33·0%] of 379 patients) and enthesitis-related arthritis (113 [29·8%] of 379) were more common in southeast Asia, whereas oligoarthritis was more prevalent in southern Europe (1360 [56·7%] of 2400) and rheumatoid factor-negative polyarthritis was more frequent in North America (165 [31·5%] of 523) than in the other areas. Prevalence of uveitis was highest in northern Europe (161 [19·1%] of 845 patients) and southern Europe (450 [18·8%] of 2400) and lowest in Latin America (54 [6·4%] of 849), Africa and Middle East (71 [5·9%] of 1209), and southeast Asia (19 [5·0%] of 379). Median age at disease onset was lower in southern Europe (3·5 years, IQR 1·9-7·3) than in other regions. Biological, disease-modifying antirheumatic drugs were prescribed more frequently in northern Europe and North America than in other geographical settings. Patients living in countries with lower GDP had greater disease activity and damage than those living in wealthier countries. Damage was associated with referral delay | ||
| 520 | |a INTERPRETATION: Our study documents a variability in prevalence of disease phenotypes and disparities in therapeutic choices and outcomes across geographical areas and wealth status of countries. The greater disease burden in lower-resource settings highlights the need for public health efforts aimed at improving equity in access to effective treatments and care for juvenile idiopathic arthritis | ||
| 520 | |a FUNDING: IRCCS Istituto Giannina Gaslini | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 700 | 1 | |a Giancane, Gabriella |e verfasserin |4 aut | |
| 700 | 1 | |a Alongi, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a van Dijkhuizen, Evert Hendrik Pieter |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Amita |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Mayouf, Sulaiman M |e verfasserin |4 aut | |
| 700 | 1 | |a Bovis, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a De Inocencio, Jaime |e verfasserin |4 aut | |
| 700 | 1 | |a Demirkaya, Erkan |e verfasserin |4 aut | |
| 700 | 1 | |a Flato, Berit |e verfasserin |4 aut | |
| 700 | 1 | |a Foell, Dirk |e verfasserin |4 aut | |
| 700 | 1 | |a Garay, Stella Maris |e verfasserin |4 aut | |
| 700 | 1 | |a Lazăr, Călin |e verfasserin |4 aut | |
| 700 | 1 | |a Lovell, Daniel J |e verfasserin |4 aut | |
| 700 | 1 | |a Montobbio, Carolina |e verfasserin |4 aut | |
| 700 | 1 | |a Miettunen, Paivi |e verfasserin |4 aut | |
| 700 | 1 | |a Mihaylova, Dimitrina |e verfasserin |4 aut | |
| 700 | 1 | |a Nielsen, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Orban, Ilonka |e verfasserin |4 aut | |
| 700 | 1 | |a Rumba-Rozenfelde, Ingrida |e verfasserin |4 aut | |
| 700 | 1 | |a Magalhães, Claudia Saad |e verfasserin |4 aut | |
| 700 | 1 | |a Shafaie, Nahid |e verfasserin |4 aut | |
| 700 | 1 | |a Susic, Gordana |e verfasserin |4 aut | |
| 700 | 1 | |a Trachana, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Wulffraat, Nico |e verfasserin |4 aut | |
| 700 | 1 | |a Pistorio, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Martini, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Ruperto, Nicolino |e verfasserin |4 aut | |
| 700 | 1 | |a Ravelli, Angelo |e verfasserin |4 aut | |
| 700 | 0 | |a Paediatric Rheumatology International Trials Organisation |e verfasserin |4 aut | |
| 700 | 1 | |a Abdwani, Reem |e investigator |4 oth | |
| 700 | 1 | |a Aghighi, Yahya |e investigator |4 oth | |
| 700 | 1 | |a Aiche, Maya-Feriel |e investigator |4 oth | |
| 700 | 1 | |a Ailioaie, Constantin |e investigator |4 oth | |
| 700 | 1 | |a Aktay Ayaz, Nuray |e investigator |4 oth | |
| 700 | 1 | |a Al-Abrawi, Safiya |e investigator |4 oth | |
| 700 | 1 | |a Alexeeva, Ekaterina |e investigator |4 oth | |
| 700 | 1 | |a Anton, Jordi |e investigator |4 oth | |
| 700 | 1 | |a Apostol, Adriana |e investigator |4 oth | |
| 700 | 1 | |a Arguedas, Olga |e investigator |4 oth | |
| 700 | 1 | |a Avcin, Tadej |e investigator |4 oth | |
| 700 | 1 | |a Barone, Patrizia |e investigator |4 oth | |
| 700 | 1 | |a Berntson, Lillemor |e investigator |4 oth | |
| 700 | 1 | |a Boteanu, Alina Lucica |e investigator |4 oth | |
| 700 | 1 | |a Boyko, Yaryna |e investigator |4 oth | |
| 700 | 1 | |a Burgos-Vargas, Ruben |e investigator |4 oth | |
| 700 | 1 | |a Calvo Penades, Inmaculada |e investigator |4 oth | |
| 700 | 1 | |a Chédeville, Gaëlle |e investigator |4 oth | |
| 700 | 1 | |a Cimaz, Rolando |e investigator |4 oth | |
| 700 | 1 | |a Civino, Adele |e investigator |4 oth | |
| 700 | 1 | |a Consolini, Rita |e investigator |4 oth | |
| 700 | 1 | |a Constantin, Tamas |e investigator |4 oth | |
| 700 | 1 | |a Cuttica, Ruben |e investigator |4 oth | |
| 700 | 1 | |a Dallos, Tomas |e investigator |4 oth | |
| 700 | 1 | |a Martin, Neil |e investigator |4 oth | |
| 700 | 1 | |a Magni Manzoni, Silvia |e investigator |4 oth | |
| 700 | 1 | |a De Cunto, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Dolezalova, Pavla |e investigator |4 oth | |
| 700 | 1 | |a Ekelund, Maria |e investigator |4 oth | |
| 700 | 1 | |a El Miedany, Yasser |e investigator |4 oth | |
| 700 | 1 | |a Espada, Graciela |e investigator |4 oth | |
| 700 | 1 | |a Estmann Christensen, Anne |e investigator |4 oth | |
| 700 | 1 | |a Foeldvari, Ivan |e investigator |4 oth | |
| 700 | 1 | |a Gallizzi, Romina |e investigator |4 oth | |
| 700 | 1 | |a Ganser, Gerd |e investigator |4 oth | |
| 700 | 1 | |a Gerloni, Valeria |e investigator |4 oth | |
| 700 | 1 | |a Haas, Johannes-Peter |e investigator |4 oth | |
| 700 | 1 | |a Harel, Liora |e investigator |4 oth | |
| 700 | 1 | |a Harjacek, Miroslav |e investigator |4 oth | |
| 700 | 1 | |a Hashad, Soad |e investigator |4 oth | |
| 700 | 1 | |a Herlin, Troels |e investigator |4 oth | |
| 700 | 1 | |a Herrera, Cristina |e investigator |4 oth | |
| 700 | 1 | |a Hofer, Michael |e investigator |4 oth | |
| 700 | 1 | |a Holzinger, Dirk |e investigator |4 oth | |
| 700 | 1 | |a Horneff, Gerd |e investigator |4 oth | |
| 700 | 1 | |a Huppertz, Hans-Iko |e investigator |4 oth | |
| 700 | 1 | |a Iagăru, Nicolae |e investigator |4 oth | |
| 700 | 1 | |a Ibanez Estrella, Amparo |e investigator |4 oth | |
| 700 | 1 | |a Ioseliani, Maka |e investigator |4 oth | |
| 700 | 1 | |a Joos, Rik |e investigator |4 oth | |
| 700 | 1 | |a Knupp Oliveira, Sheila |e investigator |4 oth | |
| 700 | 1 | |a Kamphuis, Sylvia |e investigator |4 oth | |
| 700 | 1 | |a Kasapcopur, Ozgur |e investigator |4 oth | |
| 700 | 1 | |a Katsicas, Maria Martha |e investigator |4 oth | |
| 700 | 1 | |a Khubchandani, Raju |e investigator |4 oth | |
| 700 | 1 | |a Kondi, Anuela |e investigator |4 oth | |
| 700 | 1 | |a Kröger, Liisa |e investigator |4 oth | |
| 700 | 1 | |a La Torre, Francesco |e investigator |4 oth | |
| 700 | 1 | |a Laday, Matilda |e investigator |4 oth | |
| 700 | 1 | |a Lahdenne, Pekka |e investigator |4 oth | |
| 700 | 1 | |a Maggio, Maria Cristina |e investigator |4 oth | |
| 700 | 1 | |a Magnolia, Maria Greca |e investigator |4 oth | |
| 700 | 1 | |a Malagon, Clara |e investigator |4 oth | |
| 700 | 1 | |a Malin, Merja |e investigator |4 oth | |
| 700 | 1 | |a Martino, Silvana |e investigator |4 oth | |
| 700 | 1 | |a Melo-Gomes, Jose Antonio |e investigator |4 oth | |
| 700 | 1 | |a Mesa-Del-Castillo, Pablo |e investigator |4 oth | |
| 700 | 1 | |a Militaru, Andrea |e investigator |4 oth | |
| 700 | 1 | |a Minden, Kirsten |e investigator |4 oth | |
| 700 | 1 | |a Miniaci, Angela |e investigator |4 oth | |
| 700 | 1 | |a Moradinejad, Mohammad Hasan |e investigator |4 oth | |
| 700 | 1 | |a Morel Ayala, Zoilo |e investigator |4 oth | |
| 700 | 1 | |a Nikishina, Irina |e investigator |4 oth | |
| 700 | 1 | |a Norambuena, Ximena |e investigator |4 oth | |
| 700 | 1 | |a Nordal, Ellen Berit |e investigator |4 oth | |
| 700 | 1 | |a Pagava, Karaman |e investigator |4 oth | |
| 700 | 1 | |a Panaviene, Violeta |e investigator |4 oth | |
| 700 | 1 | |a Pastore, Serena |e investigator |4 oth | |
| 700 | 1 | |a Pieropan, Sara |e investigator |4 oth | |
| 700 | 1 | |a Podda, Rosa Anna |e investigator |4 oth | |
| 700 | 1 | |a Pruunsild, Chris |e investigator |4 oth | |
| 700 | 1 | |a Putto-Laurila, Anne |e investigator |4 oth | |
| 700 | 1 | |a Quartier, Pierre |e investigator |4 oth | |
| 700 | 1 | |a Remesal, Agustin |e investigator |4 oth | |
| 700 | 1 | |a Rigante, Donato |e investigator |4 oth | |
| 700 | 1 | |a Ringold, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Rutkowska-Sak, Lidia |e investigator |4 oth | |
| 700 | 1 | |a Rygg, Marite |e investigator |4 oth | |
| 700 | 1 | |a Saurenmann, Rotraud Katharina |e investigator |4 oth | |
| 700 | 1 | |a Sawhney, Sujata |e investigator |4 oth | |
| 700 | 1 | |a Scott, Christiaan |e investigator |4 oth | |
| 700 | 1 | |a Shiari, Reza |e investigator |4 oth | |
| 700 | 1 | |a Smolewska, Elzbieta |e investigator |4 oth | |
| 700 | 1 | |a Sozeri, Betul |e investigator |4 oth | |
| 700 | 1 | |a Swart, Joost Frans |e investigator |4 oth | |
| 700 | 1 | |a Sztajnbok, Flavio |e investigator |4 oth | |
| 700 | 1 | |a Torcoletti, Marta |e investigator |4 oth | |
| 700 | 1 | |a Tsitsami, Elena |e investigator |4 oth | |
| 700 | 1 | |a Tzaribachev, Nikolay |e investigator |4 oth | |
| 700 | 1 | |a Unsal, Erbil |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Child & adolescent health |d 2017 |g 3(2019), 4 vom: 07. Apr., Seite 255-263 |w (DE-627)NLM27703082X |x 2352-4650 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2019 |g number:4 |g day:07 |g month:04 |g pages:255-263 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2352-4642(19)30027-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2019 |e 4 |b 07 |c 04 |h 255-263 | ||